A
Adolf Bauernfeind
Researcher at Ludwig Maximilian University of Munich
Publications - 65
Citations - 3170
Adolf Bauernfeind is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Klebsiella pneumoniae & Cystic fibrosis. The author has an hindex of 28, co-authored 65 publications receiving 3065 citations.
Papers
More filters
Journal ArticleDOI
A new plasmidic cefotaximase in a clinical isolate of Escherichia coli.
TL;DR: The cefotaximase of E. coli GRI represents a new plasmidic (plasmid pMVP-3) broad spectrum β-lactamase (CTX-M) which may not be closely related to either the TEM- oder SHV-family of extended broad spectrumβ- lactamases.
Journal ArticleDOI
Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases.
TL;DR: The cefotaximases CTX-M-1/MEN-1 and CTX -M-2 represent two members of a new subgroup of plasmidic class A beta-lactamases.
Journal ArticleDOI
Cefotaxime-Resistant Enterobacteriaceae Isolates from a Hospital in Warsaw, Poland: Identification of a New CTX-M-3 Cefotaxime-Hydrolyzing β-Lactamase That Is Closely Related to the CTX-M-1/MEN-1 Enzyme
Marek Gniadkowski,Ines Schneider,Andrzej Pałucha,Renate Jungwirth,Barbara Mikiewicz,Adolf Bauernfeind +5 more
TL;DR: The results suggest that CTX-M genes have been spread among different species of the familyEnterobacteriaceae in the hospital and that the CTx-M-3-expressing C. freundii strain causing routine urinary tract infections has been maintained for a relatively long time in thehospital environment.
Journal ArticleDOI
A new plasmidic cefotaximase from patients infected with Salmonella typhimurium.
Adolf Bauernfeind,M. Holley,R. Jungwirth,P. Mangold,T. Röhnisch,S. Schweighart,R. Wilhelm,J M Casellas,M. Goldberg +8 more
TL;DR: Salmonella typhimurium strains resistant to most β-lactams, co-trimoxazole, tobramycin and gentamicin were isolated from patients in Buenos Aires, Argentina, beginning in August 1990, and produced a plasmidic (pMVP-4) extended broad-spectrum β- lactamase which is more active against cefotaxime than against ceftazidime.
Journal ArticleDOI
Placebo‐controlled, double‐blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis
Heinz Georg Wiesemann,Gratiana Steinkamp,Felix Ratjen,Adolf Bauernfeind,Barbara Przyklenk,Gerd Döring,Horst von der Hardt +6 more
TL;DR: In chronic Pseudomonas aeruginosa pulmonary infection of patients with cystic fibrosis, antibiotic therapy generally fails to eradicate the bacterial pathogen.